Investors

Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.

We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.

Recent News

Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update

– Continued Remediation Progress Being Made – Reiterating Prior Guidance of Informing FDA on Inspection Readiness During...

Learn More

Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020

BUENA, N.J. , May 21, 2021 (GLOBE NEWSWIRE) -- Teligent , Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jers...

Learn More

Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update

– Significantly strengthened balance sheet and cash position – Continued FDA Warning Letter remediation efforts – Antici...

Learn More

Events

Investor Overview

There are no items to display.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.